皓元医药 (688131.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(皓元医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,376,113,868.75880,918,116.49418,365,040.621,358,053,975.22970,166,270.34621,311,676.21299,992,261.46
 营业利润(元) 133,796,677.72111,364,575.3447,936,796.00196,567,219.28167,437,231.19123,505,258.5967,898,249.96
 利润总额(元) 132,797,955.07110,071,289.6148,038,532.49198,543,113.99168,455,421.98123,545,391.6567,888,149.30
 净利润(元) 116,758,100.5993,874,503.5546,068,348.53191,557,590.58155,926,398.04115,179,557.0661,771,891.90
 归属于母公司股东的净利润(元) 118,164,770.8894,855,976.2546,235,560.46193,643,498.25157,849,635.63116,382,646.4062,338,825.02
盈利能力:
 销售毛利率(%) 48.3450.0950.3351.4453.3056.2757.48
 销售净利率(%) 8.4810.6611.0114.1116.0718.5420.59
 净资产收益率(%) 5.324.372.17----
 总资产报酬率ROA(%) 4.413.581.80----
 投入资本回报率ROIC(%) 3.853.161.588.307.675.853.18
营运能力:
 存货周转率(次) 0.740.500.28----
 应收账款周转率(次) 3.472.331.35----
 总资产周转率(次) 0.400.270.13----
偿债能力:
 资产负债率(%) 39.8738.6537.1135.1828.8026.5524.26
 股东权益比率(%) 59.8761.0762.5864.4870.7672.9675.19
 已获利息倍数(倍) 7.8314.506.50-342.77-63.36-313.8960.37
 流动比率 1.931.982.142.223.354.375.58
 速动比率 0.730.660.750.931.722.643.96
发展能力:
 营业收入增长率(%) 41.8441.7839.4640.1239.3836.5233.02
 营业利润增长率(%) -20.09-9.83-29.40-6.29-1.6314.275.29
 税后利润增长率(%) -25.14-18.50-25.831.399.6322.5115.06
 净资产增长率(%) 24.8826.7626.3627.3111.1710.88223.93
 总资产增长率(%) 47.6151.4551.8350.8828.8321.51159.40

前瞻产业研究院